Prognostic Factors in Hormone-sensitive Prostate Cancer Patients Treated With Combined Androgen Blockade: A Consecutive 15-year Study at a Single Japanese Institute

Miyazawa, Y; Sekine, Y; Arai, S; Oka, D; Nakayama, H; Syuto, T; Nomura, M; Koike, H; Matsui, H; Shibata, Y; Suzuki, K

Miyazawa, Y (corresponding author), Gunma Univ, Dept Urol, Grad Sch Med, 3-9-22 Showa Machi, Maebashi, Gunma 3718511, Japan.

IN VIVO, 2021; 35 (1): 373

Abstract

Background/Aim: There are several treatment options for metastatic hormone-sensitive prostate cancer (mHSPC) in the world. In recent years, the use of......

Full Text Link